| mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.004 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.006 |
| mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.02 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.02 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.02 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.03 |
| mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.03 |